Pharmaceutical composition comprising HIV protease inhibiting compounds
US5725878A · kind A · utility
42Cited by
4References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 1995 |
| Grant date | Mar 10, 1998 |
| Priority date | — |
| Expiry date | May 4, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition is disclosed which comprises a solution of an HIV protease inhibiting compound in a pharmaceutically acceptable organic solvent comprising a pharmaceutically acceptable alcohol. The composition can optionally comprise a pharmaceutically acceptable acid or a combination of pharmaceutically acceptable acids. The solution can optionally be encapsulated in hard gelatin capsules or soft elastic gelatin capsules. The solution can optionally be granulated with a pharmaceutically acceptable granulating agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.